Hormonal regulation of alternative splicing

Frontiers of Hormone Research

Volumn 25, Issue , 1999, Pages 1-17

  Webster, Nicholas J G ^a   Huang, Ze ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; INSULIN RECEPTOR; MESSENGER RNA; RNA PRECURSOR;

ALTERNATIVE RNA SPLICING; ANIMAL; CELL LINE; DRUG EFFECT; GENETICS; HUMAN; REVIEW;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; HORMONES; HUMANS; RECEPTOR, INSULIN; RNA PRECURSORS; RNA, MESSENGER;

EID: 0033290866     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060994     Document Type: Article

References (86)

1. Sharp PA: Split genes and RNA splicing. Cell 1994;77:805-815.
2. Guthrie C: Messenger RNA splicing in yeast: clues to why the spliceosome is a ribonucleoprotein. Science 1991;253:157-163.
3. Ruby SW, Ableson J: Pre-mRNA splicing in yeast. Trends Genet 1991;7:79-85.
4. Maniatis T: Mechanisms of alternative pre-mRNA splicing. Science 1991;251:33-34.
5. Latchman DS: Cell-type-specific splicing factors and the regulation of alternative splicing. New Biol 1990;2:297-303.
6. McKeown M: Alternative mRNA splicing. Annu Rev Cell Biol 1992;8:133-155.
7. Eperon LP, Graham IR, Griffiths AD, Eperon IC: Effects of RNA secondary structure on alternative splicing of pre-mRNA: Is folding limited to a region behind the transcribing RNA polymerase? Cell 1988;54:393-401.
8. Solnick D, Lee SI: Amount of RNA secondary structure required to induce an alternative splice. Mol Cell Biol 1987;7:3194-3198.
9. Solnick D: Alternative splicing caused by RNA secondary structure. Cell 1985;43:667-676.
10. Balvay L, Libri D, Fiszman MY: Pre-mRNA secondary structure and the regulation of splicing. Bio Essays 1993;15:165-169.
11. Sterner DA, Berget SM: In vivo recognition of a vertebrate mini-exon as an exon-intron-exon unit. Mol Cell Biol 1993;13:2677-2687.
12. Furdon PJ, Kole R: The length of the downstream exon and the substitution of specific sequences affect pre-mRNA splicing in vitro. Mol Cell Biol 1988;8:860-866.
13. Nelson KK, Green MR: Mechanism for cryptic splice site activation during pre-mRNA splicing. Proc Natl Acad Sci USA 1990;87:6253-6257.
14. Lear AL, Eperon LP, Wheatley IM, Eperon IC: Hierarchy for 5′ splice site preference determined in vivo. J Mol Biol 1990;211:103-115.
15. Eperon IC, Ireland DC, Smith RA, Mayeda A, Krainer AR: Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J 1993;12:3607-3617.
16. Khotz JD, Jamison SF, Will CL, Zuo P, Luhrmann R, Garcia-Blanco MA, Manley JL: Proteinprotein interactions and 5′-splice-site recognition mRNA precursors. Nature 1994;368:119-124.
17. Staknis D, Reed R: Direct interactions between pre-mRNA and six U2 small nuclear ribonucleoproteins during spliceosome assembly. Mol Cell Biol 1994;14:2994-3005.
18. Zahler AM, Roth MB: Distinct functions of SR proteins in recruitment of U1 small nuclear ribonucleoprotein to alternative 5′ splice sites. Proc Natl Acad Sci USA 1995;92:2642-2646.
19. Ramchatesingh J, Zahler AM, Neugebauer KM, Roth MB, Cooper TA: A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol Cell Biol 1995;15:4898-4907.
20. Caceres JF, Stamm S, Helfman DM, Krainer AR: Regulation of alternative splicing in vivo by overexpression of antogonistic splicing factors. Science 1994;265:1706-1709.
21. Sun Q, Mayeda A, Hampson RK, Krainer AR, Rottman FM: General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev 1993;7:2598-2608.
22. Mayeda A, Helfman DM, Krainer AR: Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol Cell Biol 1993;13:2993-3001.
23. Sell SM, Reese D, Ossowski VM: Insulin-inducible changes in insulin receptorm RNA splice variants. J Biol Chem 1994;269:30769-30772.
24. Kosaki A, Webster NJ: Effect of dexamethasone on the alternative splicing of the insulin receptor nRNA and insulin action in HepG2 hepatoma cells. J Biol Chem 1993;268:21900-21996.
25. Norgren S, Li LS, Luthman H: Regulation of human insulin receptor RNA splicing in HepG2 cells:effects of glucocorticoid and low glucose concentration. Biochem Biophys Res Commun 1994;199;277-284.
26. Cote GJ, Gagle RF: Dexamethasone differentially affects the levels of calcitonin and calcitonin gene-related peptide mRNAs expressed in a human medullary thyroid carcinoma cell line. J Biol Chem 1986;261:15524-15528.
27. Chalfant CE, Mischak H,Watson JE,Winkler BC, Goodnight J, Ferase RV, Cooper DR: Regulation of alternative splicing of protein kinase Cb by insulin. J Biol Chem 1995;270:13326-13332.
28. Chalfant CE, Watson JE, Bisnauth LD, Kang JB, Patel N, Obeid LM, Eichler DC, Cooper DR: Insulin regulates protein kinase CbetaII expression through enhanced exon inclusion in L6 skeletal muscle cells. A novel mechanism of insulin- and insulin-like growth factor-I-induced 5′ splice site selection. J Biol Chem 1998;273:910-916.
29. Chew SL, Lavender P, Clark AJL, Ross RJM: An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 1995;136:1939-1944.
30. Zhao X-M, Frist WH, Yeoh T-K, Miller GG: Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection. J Clin Invest 1994;94:992-1003.
31. Jarrous N, Osman F, Kaempfer R: 2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA. Mol Cell Biol 1996;16:2814-2822.
32. Shifrin VI, Neel BG: Growth factor-inducible alternative splicing of nontransmembrane phosphotyrosine phosphatase PTP-1B pre-mRNA. J Biol Chem 1993;268:25376-25384.
33. Neel H, Gondran P, Weil D, Dautry F: Regulation of pre-mRNA processing by src. Curr Biol. 1995;5:413-422.
34. 2+. Curr Biol 1996;6:1642-1652.
35. Fichter M, Hinrichs R, Eissner G, Scheffer B, Classen S, Ueffing M: Expression of CD44 isoforms in neuroblatoma cells is regulated by PI 3-kinase and protein kinase C. Oncogene 1997;14:2817-2824.
36. Hirano F, Hirano H, Hino E, Takayama S, Saito K, Kusumoto Y, Shimabukuro Y, Murakami S, Okada H: CD44 isoformexpression in periodontal tissues: Cell-type specific regulation of alternative splicing. J Periodontal Res 1997;32:634-645.
37. McKay NG, Hunter DJ, Haites NE, Power DA: Regulation of alternative splicing of the fibronectin IIICS domain by cytokines. Biochem Biophys Res Commun 1994;199:1005-1011.
38. Du K, Peng Y, Greenbaum LE, Haber BA, Taub R: HRS/SRp40-mediated inclusion of the fibronectin EIIIB exon, a possible cause of increased EIIIB expression in proliferating liver. Moll Cell Biol 1997;17:4096-4104.
39. Smith MA, Fanger GR, O'Connor LT, Bridle P, Maue RA: Selective regulation of agrin mRNA induction and alternative splicing in PC12 cells by ras-dependent actions of nerve growth factor. J Biol Chem 1997;272:15675-15681.
40. Jumaa H, Guenet JL, Neilsen PJ: Regulated expression and RNA processing of transcripts from the SRp20 splicing factor gene during the cell cycle. Mol Cell Biol 1997;17:3116-3124.
41. Parruti G, Peracchia F, Sallese M, Ambrosini G, Masini M, Rotilio D, De Blasi A: Molecular analysis of human beta-arrestin-1: Cloning, tissue distribution, and regulation of expression. Identification of two isoforms generated by alternative splicing. J Biol Chem 1993;268:9753-9761.
42. You S, Silsby JL, Farris J, Foster DN, el Halawani ME: Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion. Endocrinology 1995;136:2602-2610.
43. Schischmanoff PO, Yaswen P, Parra MK, Lee G, Chasis JA, Mohandas N, Conboy JG: Cell shapedependent regulation of protein 4.1 alternative pre-mRNA splicing in mammary epithelial cells. J Biol Chem 1997;272:10254-10259.
44. Diaz-Sanchez D, Zhang K, Nutman TB, Saxon A: Differential regulation of alternative 3′ splicing of epsilon messenger RNA variants. J Immunol 1995;155:1930-1941.
45. Wang JH, Shen LP, Najafi H, Kolberg JO, Matschinksy FM, Urdea M, German M: Regulation of insulin preRNA splicing by glucose. Proc Natl Acad Sci USA 1997;94:4360-4365.
46. Kraus JE, Nadler JV, McNamara JO: Regulation of alternative splicing of NMDAR1 in the kindling model. Brain Res Mol Brain Res 1996;41:97-104.
47. Diamond RH, Du K, Lee VM, Mohn KL, Haber BA, Tewar DS, Taub R: Novel delayed-early and highly insulin-induced growth response genes: Identification of HRS, a potential regulator of alternative pre-mRNA splicing. J Biol Chem 1993;268:15185-15192.
48. Gui JF, Tronchere H, Chandler SD, Fu XD: Purification and characterization of akinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc Natl Acad Sci USA 1994;91:10824-10828.
49. Gui JF, Lane WS, Fu XD: A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 1994;369:678-682.
50. Colwill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC, Duncan PI: The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 1996;15:265-275.
51. Colwill K, Feng LL, Yeakley JM, Gish GD, Cáceres JF, Pawson T, Fu XD: SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. J Biol Chem 1996;271:24569-24575.
52. Rossi F, Labourier E, Forne T, Divita G, Derancourt J, Riou JF, Antoine E, Cathala G, Brunel C, Tazi J: Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature 1996;381:80-82.
53. Tacke R, Chen Y, Manley JL: Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: Creation of an SRp40-specific splicing enhancer. Proc Natl Acad Sci USA 1997;94:1148-1153.
54. Duncan PI, Stojdl DF, Marius RM, Bell JC: In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol Cell Biol 1997;17:5996-6001.
55. Mermoud JE, Cohen PT, Lamond AI: Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. EMBO J 1994;13:5679-5688.
56. Ross J: mRNA stability in mammalian cells. Microbiol Rev 1995;59:423-450.
57. Seino S, Seino M, Nishi S, Bell GI: Structure of the human insulin receptor gene and characterization of its promotor. Proc Natl Acad Sci USA 1989;86:114-118.
58. Mosthaf L, Grako K, Dull TJ, Coussens L, Ullrich A, McClain DA: Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J 1990;9:2409-2413.
59. Seino S, Bell GI: Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 1989;159:312-316.
60. Moller DE, Yokota A, Caro JF, Flier JS: Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 1989;1263-1269.
61. Goldtein BJ, Dudley AL: The rat insulin receptor: Primary structure and conservation of tissuespecific alternative messenger RNA splicing. Mol Endocrinol 1990;4:235-244.
62. Yamaguchi Y, Flier JS, Benecke H, Ransil BJ, Moller DE: Ligand-binding properties of the two isoforms of the human insulin receptor. Endocrinology 1993;132:1132-1138.
63. Pashmforoush M, Yoshimasa Y, Steiner DF: Exon 11 enhances insulin binding affinity and tyrosine kinase activity of the human insulin proreceptor. J Biol Chem 1994;269:32639-32648.
64. Vogt B, Carrascosa JM, Ermel B, Ullrich A, Haring HU: The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun 1991;177:1013-1018.
65. Yamaguchi Y, Flier JS, Yokota A, Benecke H, Backer JM, Moller DE: Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 1991;129:2058-2066.
66. McClain DA: Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 1991;5:734-739.
67. Kellerer M, Lammers R, Ermel B, Tippmer S, Vogt B, Obermaier-Kusser B, Ullrich A, Haring HU: Distinct alpha-subunit structures of human receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 1992;31:4588-4596.
68. Kosaki A, Pillay TS, Xu L,Webster NJ: The B isoform of the insulin receptor signals more efficiently that the A isoform in HepG2 cells. J Biol Chem 1995;270:20816-20823.
69. Mosthaf L, Vogt B, Haring HU, Ullrich A: Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci USA 1991;88:4728-4730.
70. Sesti G, Marini MA, Tullio AN, Montemurro A, Borboni P, Fusco A, Accili D, Lauro R: Altered expression of thetwonaturallyoccurringhumaninsulin receptorvariants in isolated adipocytes ofnoninsulin-dependent diabetes mellitus patients. Biochem Biophys Res Commun 1991;181:1419-1424.
71. Benecke H, Flier JS, Moller DE: Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues. J Clin Invest 1992;89:2066-2070.
72. Mosthaf L, Eriksson J, Haring HU, Groop L, Widen E, Ullrich A: Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes. Proc Natl Acad Sci USA 1993;90:2633-2635.
73. Kellerer M, Sesti G, Seffer E, Obermaier-Kusser B, Pongratz DE, Mosthaf L, Haring HU: Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1993;36:628-632.
74. Anderson CM, Henry RR, Knudson PE, Olefsky JM, Webster NJ: Relative expression of insulin receptor isoforms does not differ in lean, obese, and noninsulin-dependent diabetes mellitus subjects. J Clin Endocrinol Metab 1993;76:1380-1382.
75. Hansen T, Bjorbaek C, Vestergaard H, Gronskov K, Bak JF, Pedersen O: Expression of insulin receptor spliced variants and their functional correlates in muscle from patients with non-insulindependent diabetes mellitus. J Clin Endocrinol Metab 1993;77:1500-1505.
76. Norgen S, Zierath J, Galuska D, Wallberg-Henriksson H, Luthman H: Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients. The RNA variant without exon 11 predominates in both groups. Diabetes 1993;42:675-681.
77. Sbraccia P, D'Adamo M, Leonetti F, Caiola S, Iozzo P, Giaccari A, Buongiorno A, Tamburrano G: Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetologia 1996;39:220-225.
78. Hansen BC: Obesity and diabetes in monkeys; in Bjorntrop P, Brodoff B (eds): Obesity. Philadelphia, Lippincott, 1992, pp 256-265.
79. Huang Z, Bodkin NL, Ortmeyer HK, Hansen BC, Shuldiner AR: Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey. J Clin Invest 1994;94:1289-1296.
80. Huang Z, Bodkin NL, Ortmeyer HK, Zenilman ME, Webster NJG, Hansen BC, Shuldiner AR: Altered insulin receptor messenger ribonucleic acid splicing in liver is associated with deterioration of glucose tolerance in the spontaneously obese and diabetic rhesus monkey: Analysis of controversy between monkey and human studies. J Clin Endocrinol Metab 1996;81:1552-1556.
81. Norgen S, Zierath J, Wedell A, Wallberg-Henriksson H, Luthman H: Regulation of human insulin receptor RNA splicing in vivo. Proc Natl Acad Sci USA 1994;91:1465-1469.
82. Van der Vorm ER, Maassen JA: Alternative splicing of the insulin receptor isoforms is altered in patients with leprechaunism. Horm Metab Res 1994;26:599-601.
83. Vidal H, Auboeuf D, Beylot M, Riou JP: Regulation of insulin receptor mRNA splicing in rat tissues. Effect of fasting, aging, and diabetes. Diabetes 1995;44:1196-1201.
84. Wiersma MML, Auboeuf D, Nieuwenhuizen-Bakker IM, Radder JK, Riou JP, Vidal H: Insulin receptor mRNA splicing and altered metabolic control in aged and mildly insulin-deficient rats. Am J Physiol Endocrinol Metab 1997;272:E607-E615.
85. Kim Y, Tamura T, Iwashita S, Tokuyama K, Suzuki M: Effect of high-fat diet on gene expression of GLUT4 and insulin receptor in soleus muscle. Biochem Biophys Res Commun 1994;202:519-526.
86. Laville M, Auboeuf D, Khalfallah Y, Vega N, Riou JP, Vidal H: Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J Clin Invest 1996;98:43-49.